Page 1 | Search Results | Blood Advances | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Toshihito Hirai, Po-Yu Lin, Federico Simonetta, Kristina Maas-Bauer, Mustafa Turkoz, Melissa Mavers, Jeanette Baker, Robert S. Negrin

Blood Adv (2021) 5 (11): 2528–2538.

https://doi.org/10.1182/bloodadvances.2020003272

Published: 2021

Includes: Supplemental data

Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk

Blood Adv (2021) 5 (8): 2196–2215.

https://doi.org/10.1182/bloodadvances.2020003805

Published: 2021

Includes: Supplemental data

Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar

Blood Adv (2021) 5 (5): 1425–1436.

https://doi.org/10.1182/bloodadvances.2020003219

Published: 2021

Includes: Supplemental data

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Kamira Maharaj, John J. Powers, Alex Achille, Melanie Mediavilla-Varela, Wael Gamal, Karen L. Burger, Renee Fonseca, Kun Jiang, Hari P. Miskin, Dave Maryanski, Andrii Monastyrskyi, Derek R. Duckett, William R. Roush, John L. Cleveland, Eva Sahakian, Javier Pinilla-Ibarz

Blood Adv (2020) 4 (13): 3072–3084.

https://doi.org/10.1182/bloodadvances.2020001800

Published: 2020

Includes: Supplemental data

Journal Articles

Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8 + T-cell responses

Alak Manna, Timothy Kellett, Sonikpreet Aulakh, Laura J. Lewis-Tuffin, Navnita Dutta, Keith Knutson, Eduardo Chini, Javier Pinilla-Ibarz, Nicole Lamanna, Rami Manochakian, Fabio Malavasi, Taimur Sher, Asher A. Chanan-Khan, Sikander Ailawadhi, Aneel Paulus

Blood Adv (2020) 4 (10): 2143–2157.

https://doi.org/10.1182/bloodadvances.2019001091

Published: 2020

Includes: Supplemental data

Journal Articles

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Scott N. Furlan, Karnail Singh, Christina Lopez, Victor Tkachev, Daniel Joel Hunt, James Hibbard, Kayla M. Betz, Bruce R. Blazar, Cole Trapnell, Leslie S. Kean

Blood Adv (2020) 4 (8): 1594–1605.

https://doi.org/10.1182/bloodadvances.2019001248

Published: 2020

Includes: Supplemental data

Journal Articles

Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells

Amara Seng, Kelsey L. Krausz, Dong Pei, Devin C. Koestler, Ryan T. Fischer, Thomas M. Yankee, Mary A. Markiewicz

Blood Adv (2020) 4 (7): 1325–1339.

https://doi.org/10.1182/bloodadvances.2019000965

Published: 2020

Includes: Supplemental data

Journal Articles

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Blood Adv (2020) 4 (7): 1284–1295.

https://doi.org/10.1182/bloodadvances.2019001259

Published: 2020

Includes: Supplemental data

Journal Articles

Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation

John S. Riley, Lauren E. McClain, John D. Stratigis, Barbara E. Coons, Nicholas J. Ahn, Haiying Li, Stavros P. Loukogeorgakis, Camila G. Fachin, Andre I. B. S. Dias, Alan W. Flake, William H. Peranteau

Blood Adv (2020) 4 (6): 1102–1114.

https://doi.org/10.1182/bloodadvances.2019001208

Published: 2020

Includes: Supplemental data

Journal Articles

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Andrea S. Henden, Antiopi Varelias, Justine Leach, Elise Sturgeon, Judy Avery, Jessica Kelly, Stuart Olver, Luke Samson, Gunter Hartel, Simon Durrant, Jason Butler, Anthony J. Morton, Ashish Misra, Siok-Keen Tey, Elango Subramoniapillai, Cameron Curley, Glen Kennedy, Geoffrey R. Hill

Blood Adv (2019) 3 (20): 3013–3019.

https://doi.org/10.1182/bloodadvances.2019000453

Published: 2019

Includes: Supplemental data

Journal Articles

Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells

Francesca A. M. Kinsella, Jianmin Zuo, Charlotte F. Inman, Hayden Pearce, Luke Maggs, Suzy E. Eldershaw, Y. L. Tracey Chan, Jane Nunnick, Sandeep Nagra, Mike Griffiths, Charles Craddock, Ram Malladi, Paul Moss

Blood Adv (2019) 3 (5): 734–743.

https://doi.org/10.1182/bloodadvances.2018025502

Published: 2019

Includes: Supplemental data

Journal Articles

B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell–dominant T-cell responses via IL-33

Hiroshi Arima, Momoko Nishikori, Yasuyuki Otsuka, Wataru Kishimoto, Kiyotaka Izumi, Koubun Yasuda, Tomohiro Yoshimoto, Akifumi Takaori-Kondo

Blood Adv (2018) 2 (18): 2282–2295.

https://doi.org/10.1182/bloodadvances.2018019919

Published: 2018

Includes: Supplemental data

Journal Articles

Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients

Lucas C. M. Arruda, Kelen C. R. Malmegrim, João R. Lima-Júnior, Emmanuel Clave, Juliana B. E. Dias, Daniela A. Moraes, Corinne Douay, Isabelle Fournier, Hélène Moins-Teisserenc, Antônio José Alberdi, Dimas T. Covas, Belinda P. Simões, Pauline Lansiaux, Antoine Toubert, Maria Carolina Oliveira

Blood Adv (2018) 2 (2): 126–141.

https://doi.org/10.1182/bloodadvances.2017011072

Published: 2018

Includes: Supplemental data

Journal Articles

Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified

Shoko Nakayama, Taiji Yokote, Toshikazu Akioka, Nobuya Hiraoka, Uta Nishiwaki, Takuji Miyoshi, Kazuki Iwaki, Ayami Takayama, Yuki Masuda, Jun Hatooka, Mayumi Fujimoto, Yasuichiro Nishimura, Motomu Tsuji

Blood Adv (2017) 1 (8): 486–493.

https://doi.org/10.1182/bloodadvances.2016000885

Published: 2017

Includes: Supplemental data

Journal Articles

TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice

Dipica Haribhai, Xiaofeng Luo, Juan Chen, Shuang Jia, Linzheng Shi, Jocelyn A. Schroeder, Hartmut Weiler, Richard H. Aster, Martin J. Hessner, Jianda Hu, Calvin B. Williams, Qizhen Shi

Blood Adv (2016) 1 (2): 139–151.

https://doi.org/10.1182/bloodadvances.2016001453

Published: 2016

Includes: Supplemental data

NARROW

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8 + T-cell responses

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells

B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell–dominant T-cell responses via IL-33

Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients

Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified

TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only